TTD Drug ID: DAP000937

Drug Information
Name	Ritodrine
Synonyms	L000737; 4-[2-[[1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]phenol; LS-187116; CID31729; CAS-23239-51-2; EINECS 247-879-9; Prestwick0_000349; Utopar; BRD-K51465424-003-03-6; KBio2_001898; AC1LEMBZ; Benzenemethanol, 4-hydroxy-alpha-(1-((2-(4-hydroxyphenyl)ethyl)amino)ethyl)-, (R*,S*)-; D02359; Prestwick3_000349; Prestwick2_000349; RITODRINE HCL; NCGC00016773-01; Spectrum4_000438; Ritodrinium; AC1LEMBT; Spectrum_001418; Ritodrinium [INN-Latin]; CID688570; KBio2_007034; NCGC00162324-02; Ritodrina [INN-Spanish]; AC1L1PV2; Lopac0_001041; AC1L1M7Q; 4-Hydroxy-alpha-(1-((2-(4-hydroxyphenyl)ethyl)amino)ethyl)benzenemethanol (R*,S*)-; Spectrum3_001458; KBio3_002455; NCGC00015887-01; BPBio1_000459; KBio2_004466; KBioGR_000796; Ritodrine [USAN:BAN:INN]; 4-[2-[[(1R,2S)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]phenol; BRD-A59174698-003-02-9; CHEMBL83063; 2-(4-Hydroxyphenethylamino)-1-(4-hydroxyphenyl)propanol; Yutopar; SPBio_001526; CHEMBL785; NCGC00179566-01; DB00867; 4-[2-[[(1S,2S)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]phenol; AC1LEMBW; Spectrum2_001423; LS-30764; Ritodrina; erythro-p-Hydroxy-alpha-(1-((p-hydroxyphenethyl)amino)ethyl)benzyl alcohol; 4-[2-[[(1S,2R)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]phenol; UNII-I0Q6O6740J; Ritodrine (USAN/INN); AC1Q59PF; BSPBio_000417; Yutopar S.R; NCGC00162324-01; Benzyl alcohol, p-hydroxy-alpha-(1-((p-hydroxyphenethyl)amino)ethyl)-, erythro-; SPBio_002338; CID688568; Prepar; Prestwick1_000349; DU-21220; Benzenemethanol, 4-hydroxy-.alpha.-[1-[[2-(4-hydroxyphenyl)ethyl]amino]ethyl]-, (R*,S*)-; AC1Q76UV; Lopac-R-0758; 4-[2-[[(1R,2R)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]phenol; Spectrum5_001225; BSPBio_002955; NCGC00015887-02; 26652-09-5; CID33572; p-Hydroxy-alpha-(1-((p-hydroxyphenethyl)amino)ethyl)benzyl alcohol; KBioSS_001898; CID688569; ritodrine; BRN 2388728; C07239
Trade Name	Yutopar
Indication	Premature labour			Approved    [1]
Structure	Click to save drug structure in 3D MOL format Click to save drug structure in 2D MOL format
Therapeutic Class	Sympathomimetics
CAS Number	CAS 26652-09-5
Formular	C17H21NO3
PubChem Compound ID	CID 31729.
PubChem Substance ID	SID 4924962.
SuperDrug ATC ID	G02CA01;
SuperDrug CAS ID	026652095;
Target	Beta adrenergic receptor			Agonist	[2][3]
Ref 1	FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 071438 To Reference
Ref 2	Acute tocolysis for uterine activity reduction in term labor: a review. Obstet Gynecol Surv. 2008 Jun;63(6):383-8; quiz 405. To Reference
Ref 3	Discovery of novel N-phenylglycine derivatives as potent and selective beta(3)-adrenoceptor agonists for the treatment of frequent urination and urinary incontinence. J Med Chem. 2001 Apr 26;44(9):1436-45. To Reference

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.